Gsk GSK
NYSE GSK
$52.41 +0.45 (+0.87%)
At close: Aug 21, 2026 · 4:00 PM EDT

Gsk (GSK) Non-cash Items (2009 - 2026)

Gsk (GSK) posted quarterly Non-cash Items of $4.3 billion for Q1 2026, down 19.45% year-over-year from $5.4 billion in Q1 2025, and down 2.46% quarter-over-quarter from $4.4 billion in Q4 2025.

Gsk (GSK) Non-cash Items (2009 - 2026) Analysis & Trends

Gsk's Non-cash Items history runs 18 years deep, the most recent figure standing at $4.3 billion for Q1 2026.

  • In Q1 2026, Non-cash Items fell 19.45% year-over-year to $4.3 billion; the TTM figure through Mar 2026 stood at $17.8 billion (up 10.44% YoY), while the FY2025 annual figure was $3.5 billion, down 44.25% from the prior year.
  • Non-cash Items for Q1 2026 stood at $4.3 billion, down from $4.4 billion in the prior quarter.
  • The five-year high for Non-cash Items was $14.4 billion in Q1 2022, with the low at $3.3 billion in Q1 2024.
  • The 5-year median for Non-cash Items is $4.3 billion (2026), against an average of $5.7 billion.
  • The sharpest annual moves came in 2022 and 2023: Non-cash Items soared 153.07% in 2022, then sank 77.07% in 2023.
  • Gsk's Non-cash Items stood at $8.7 billion in 2022, then slumped by 56.71% to $3.8 billion in 2023, then dropped by 2.0% to $3.7 billion in 2024, then grew by 19.65% to $4.4 billion in 2025, then slipped by 2.46% to $4.3 billion in 2026.
  • Business Quant data shows GSK's Non-cash Items at $4.3 billion in Q1 2026, $4.4 billion in Q4 2025, and $5.4 billion in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.31 Bn
Mar 31, 2026 4.31 Bn
Dec 31, 2025 4.42 Bn
Dec 31, 2025 4.42 Bn
Mar 31, 2025 5.35 Bn
Mar 31, 2025 5.35 Bn
Dec 31, 2024 3.70 Bn
Dec 31, 2024 3.70 Bn
Mar 31, 2024 3.28 Bn
Mar 31, 2024 3.28 Bn
Dec 31, 2023 3.77 Bn
Dec 31, 2023 3.77 Bn
Mar 31, 2023 3.31 Bn
Mar 31, 2023 3.31 Bn
Dec 31, 2022 8.71 Bn
Dec 31, 2022 8.71 Bn
Mar 31, 2022 14.43 Bn
Mar 31, 2022 14.43 Bn
Dec 31, 2021 4.72 Bn
Dec 31, 2021 4.72 Bn